Investing.com - Financial Markets Worldwide

Biomaxima (BMX)

Warsaw
Currency in PLN
13.20
+0.10(+0.76%)
Closed·
BMX Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
BMX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
12.9513.20
52 wk Range
10.5520.50
Key Statistics
Edit
Bid/Ask
13.10 / 13.20
Prev. Close
13.1
Open
12.95
Day's Range
12.95-13.2
52 wk Range
10.55-20.5
Volume
1.9K
Average Volume (3m)
9.11K
1-Year Change
-16.19%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BMX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 7
Trading at a high earnings multiple
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Biomaxima Company Profile

BioMaxima S.A. manufactures and distributes microbiological media, reagents, and equipment for in vitro diagnostics in Poland. Its primary products include analyzers and diagnostic reagents for testing the biochemical parameters of blood and other body fluids; systems for the determination of drug resistance of microorganisms; quick diagnostic tests for detecting infectious diseases, cancer markers, heart attack markers, and addictive substances and readers; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers for professional use; and analyzers for gasometric tests and critical blood parameters tests. The company also provides surfaces and air controls; antibiotics discs and MIC strips; and chromogenic, dehydrated, and prepared culture media; additives and supplements for media; microbank microorganism storage systems; and veterinary products. In addition, it engages in the devices for microbiological analysis; molecular biology products, including media for inactivating and transporting samples; and training activities. The company supplies its products to approximately 1,800 laboratories in Poland, as well as exports in the international markets. BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
126
Market
Poland

Compare BMX to Peers and Sector

Metrics to compare
BMX
Peers
Sector
Relationship
P/E Ratio
63.3x−4.7x−0.5x
PEG Ratio
0.430.010.00
Price/Book
1.2x3.2x2.6x
Price / LTM Sales
1.0x17.8x3.3x
Upside (Analyst Target)
-52.2%43.4%
Fair Value Upside
Unlock−6.4%7.1%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
0.14 / --
Revenue / Forecast
15.10M / --
EPS Revisions
a
a
Unlock
Last 90 days

BMX Income Statement

FAQ

What Stock Exchange Does Biomaxima Trade On?

Biomaxima is listed and trades on the Warsaw Stock Exchange stock exchange.

What Is the Stock Symbol for Biomaxima?

The stock symbol for Biomaxima is "BMX."

What Is the Biomaxima Market Cap?

As of today, Biomaxima market cap is 55.35M.

What Is Biomaxima's Earnings Per Share (TTM)?

The Biomaxima EPS (TTM) is 0.21.

When Is the Next Biomaxima Earnings Date?

Biomaxima will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is BMX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biomaxima Stock Split?

Biomaxima has split 0 times.

How Many Employees Does Biomaxima Have?

Biomaxima has 126 employees.

What is the current trading status of Biomaxima (BMX)?

As of 10 Aug 2025, Biomaxima (BMX) is trading at a price of 13.20, with a previous close of 13.10. The stock has fluctuated within a day range of 12.95 to 13.20, while its 52-week range spans from 10.55 to 20.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.